Evidence map›Paper›PMID 29425550›Full record

ArticleInternational journal of cardiology2018

Efficacy of intramyocardial injection of Algisyl-LVR for the treatment of ischemic heart failure in swine.

Jenny S Choy, Shuang Leng, Gabriel Acevedo-Bolton, Semion Shaul, Lijuan Fu, Xiaomei Guo, Liang Zhong, Julius M Guccione, Ghassan S Kassab

Open access · greenAbstract read
In one paragraph

Article in International journal of cardiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Effect of intra-myocardial Algisyl-LVR™ injectates on fibre structure in porcine heart failure.Journal of the mechanical behavior of biomedical materials · 2018
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Jenny S ChoyCalifornia Medical Innovations Institute, Inc., San Diego, CA, USA.
Shuang LengNational Heart Centre Singapore, Singapore, Singapore.
Gabriel Acevedo-BoltonDepartment of Surgery, University of California at San Francisco, San Francisco, CA, USA.
Semion ShaulDepartment of Surgery, University of California at San Francisco, San Francisco, CA, USA.
Lijuan FuCalifornia Medical Innovations Institute, Inc., San Diego, CA, USA.
Xiaomei GuoCalifornia Medical Innovations Institute, Inc., San Diego, CA, USA.
Liang ZhongNational Heart Centre Singapore, Singapore, Singapore; Duke-NUS Medical School, Singapore, Singapore.
Julius M GuccioneDepartment of Surgery, University of California at San Francisco, San Francisco, CA, USA.
Ghassan S KassabCalifornia Medical Innovations Institute, Inc., San Diego, CA, USA. Electronic address: gkassab@calmi2.org.
California Medical Innovations Institute · USUniversity of California, San Francisco · USDuke-NUS Medical School · SGNational Heart Centre Singapore · SG

Funding

Multi-Scale Laws of Myocardial Growth and RemodelingU01HL119578 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GUCCIONE, JULIUS MATTEO, KASSAB, GHASSAN S · 2014 to 2018
$3.8M
VIRTUAL TOOLS FOR CARDIAC VENTRICULAR REMODELING SURGERYR01HL077921 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GUCCIONE, JULIUS MATTEO · 2006 to 2015
$3.4M
Minimally Invasive Ventricular Polymeric Injection for Treatment of Heart FailureR01HL118627 · NHLBI · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI GUCCIONE, JULIUS MATTEO, KASSAB, GHASSAN S · 2013 to 2016
$3.0M
NHLBI NIH HHS R01 HL077921NHLBI NIH HHS R01 HL118627NHLBI NIH HHS U01 HL119578
6 · The paper itself

Abstract

backgroundProgressive thinning and dilation of the LV due to ischemic heart failure (IHF) increases wall stress and myocardial oxygen consumption. Injectable biopolymers implanted in the myocardial wall have been used to increase wall thickness to reduce chamber volume, decrease wall stress, and improve cardiac function. We sought to evaluate the efficacy of a biopolymer (Algisyl-LVR) to prevent left ventricular (LV) remodeling in a swine model of IHF.

methodsIHF was induced in 11 swine by occluding the marginal obtuse branches of the left circumflex artery. Eight weeks later, Algisyl-LVR was injected into the LV myocardial free wall in five of the 11 animals. Echocardiographic examinations were done every 2weeks for 16weeks.

resultsWithin eight weeks of treatment, the ejection fraction increased from 30.5%±7.7% to 42.4%±3.5% (treated group) vs. 37.3%±3.8% to 34.3%±2.9% (control), p<0.01. Stroke volume increased from 18.5±9.3mL to 41.3±13.3mL (treated group) vs. 25.4±2.3mL to 31.4±5.3mL (control), p<0.05. Wall thickness in end-diastole of the infarcted region changed from 0.69±0.06cm to 0.81±0.13cm (treated group) vs. 0.73±0.09cm to 0.68±0.11cm (control), p<0.05. Sphericity index remained almost unchanged after treatment, although differences were found at the end of the study between both groups (p<0.001). Average myofiber stress changed from 16.3±5.8kPa to 10.2±4.0kPa (treated group) vs. 15.2±4.8kPa to 17.9±5.6kPa (control), p<0.05.

conclusionsAlgisyl-LVR is an effective strategy that serves as a micro-LV assist device to reduce stress and hence prevent or reverse maladaptive cardiac remodeling caused by IHF in swine.

Indexed as

AnimalsBiopolymersDrug ImplantsHeart FailureMaleMyocardial IschemiaStroke VolumeSwineTreatment OutcomeBiopolymersDrug ImplantsAlgisylBiopolymersLV remodelingMyocardial infarctionMyofiber stressStress-related miRNA

Identifiers

PMID29425550
PMCPMC6211293
OpenAlexW2786670397

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.